About 305,000 results
Open links in new tab
Pembrolizumab improves outcomes in high-risk bladder cancer
Immunotherapy after surgery helps people with high-risk bladder cancer ...
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced …
Adjuvant Pembrolizumab: A New Option for High-Risk Muscle …
Disitamab vedotin/pembrolizumab shows promise in HER2 …
Padcev and Keytruda Double Bladder Cancer Survival - NCI
Adjuvant Pembrolizumab versus Observation in Muscle-Invasive …
FDA Approves Merck’s KEYTRUDA® (pembrolizumab) in …
PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab …
Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder …